Growth charts
Reading a growth chart
- A single point on a chart says almost nothing. The trajectory says everything
- Crossing centile lines downward = pathology until proven otherwise
- Tracking along the 3rd centile with normal velocity = usually normal
Charts used in Australia
Charts used in Australia
- WHO growth standards 0-2 years (breastfed reference population)
- CDC 2000 charts 2-18 years
- Condition-specific charts: Down syndrome, Turner syndrome, preterm (corrected age until 2 years)
Measurements that matter
- Height (supine length <2y), weight, head circumference (<3y), BMI
- Growth velocity - needs >=6 months, ideally 12, between accurate measurements
- Mid-parental height (target height)
- Boys: (mother + father + 13 cm) / 2
- Girls: (mother + father - 13 cm) / 2
- Target range = +/- 8-10 cm
- Upper:lower segment ratio and arm span - separates proportionate from disproportionate short stature
- Bone age (left hand and wrist X-ray) - compares skeletal to chronological maturity
Epidemiology
- By definition 2.3% of children are below the 2nd centile - most are normal
- Constitutional delay: M>F, commonest cause of referral for short stature and delayed puberty in boys
- GH deficiency: ~1 in 4,000-10,000
Phases of growth (Karlberg ICP model)
Phases of growth (Karlberg ICP model) - each has its own drivers
| Phase | Age | Main driver |
|---|---|---|
| Infancy | 0-2y | Nutrition |
| Childhood | 2y-puberty | GH/IGF-1 and thyroid hormone |
| Puberty | Sex steroids + GH |
- This is why the age at which growth failed points to the cause
- Sex steroids drive the pubertal growth spurt AND fuse the epiphyses - precocious puberty causes a tall child and a short adult
When to investigate short stature
- Height below the 1st centile for age and sex
- More than 2 SD below mid-parental height
- Growth velocity below the 25th centile / crossing centiles downward
- Disproportion, dysmorphism, or any red flag symptom
Differential - short stature
Normal variants (bone age is the discriminator)
- Familial short stature - short parents, bone age = chronological age, normal velocity, short adult
- Constitutional delay of growth and puberty - bone age delayed, positive family history of late puberty, normal final adult height
Systemic disease - often the whole answer
- Coeliac disease, inflammatory bowel disease (may be occult - growth failure can precede GI symptoms)
- Occult renal disease/renal tubular acidosis, chronic anaemia, cystic fibrosis, congenital heart disease
- Malnutrition
Endocrine - classically short AND overweight, with a delayed bone age
- Primary hypothyroidism - the most treatable
- GH deficiency (congenital, tumour, cranial irradiation, trauma)
- Cushing syndrome (including exogenous steroid)
- Poorly controlled T1DM (Mauriac syndrome)
- Precocious puberty - tall now, short later
Genetic / skeletal
- Turner syndrome (45,X) - check a karyotype in ANY short girl, even without stigmata
- Noonan, Prader-Willi, Silver-Russell, SHOX deficiency
- Skeletal dysplasia (achondroplasia - disproportionate, abnormal U:L ratio)
- Small for gestational age without catch-up by 2 years
Psychosocial deprivation - growth resumes on removal from the environment; the diagnostic test is a change of address
Differential - overgrowth / tall stature
- Normal variant / familial tall stature - commonest
- Klinefelter (47,XXY) - tall, reduced upper:lower segment ratio (long legs), small firm testes, gynaecomastia, learning difficulty, infertility
- Marfan syndrome - arachnodactyly, thin extremities, arm span > height, reduced U:L ratio, aortic root dilatation, upward lens subluxation, kyphoscoliosis, high-arched palate
- Homocystinuria - autosomal recessive (cystathionine beta-synthase); marfanoid habitus but downward lens subluxation, thrombosis, intellectual disability if untreated
- Homocystinuria vs Marfan is a classic pairing - the lens direction, the thromboembolism, and the inheritance separate them
- Precocious puberty, hyperthyroidism, GH excess (gigantism), Beckwith-Wiedemann, Sotos, XYY, obesity (tall child, normal adult height)
Investigation tier
- First line: FBE, ESR/CRP, UEC, LFT, calcium/phosphate, coeliac serology (with total IgA), TFT, urinalysis, karyotype in every girl
- Bone age X-ray left hand/wrist
- IGF-1 +/- IGFBP-3 as GH screen (random GH is useless - GH is pulsatile)
- GH provocation testing only after excluding systemic disease and hypothyroidism
- MRI pituitary if GH deficiency confirmed or multiple pituitary hormone deficiency
Treat the cause, not the number
- Coeliac -> gluten-free diet; IBD -> disease control and minimise steroid
- Hypothyroidism -> levothyroxine (caution: rapid catch-up can cause slipped capital femoral epiphysis and pseudotumour cerebri)
- Constitutional delay -> reassurance + growth charting; short course of low-dose testosterone (boys) if distress is significant
Growth hormone - PBS-funded indications in Australia
Growth hormone - PBS-funded indications in Australia
- GH deficiency
- Turner syndrome
- Prader-Willi syndrome
- Chronic renal insufficiency
- SHOX deficiency
- Short stature/slow growth meeting height and velocity criteria (strict auxological criteria, assessed by a paediatric endocrinologist)
- GH is not funded for idiopathic short stature on height alone
Monitoring on treatment
- Height every 3-6 months, IGF-1, TFT, glucose
- Watch for: benign intracranial hypertension, slipped capital femoral epiphysis, scoliosis progression, impaired glucose tolerance
- Stop when growth velocity <2 cm/year or epiphyses fused
Syndromes
- Turner syndrome - short stature, ovarian failure, coarctation/bicuspid aortic valve, webbed neck, renal anomaly
- Klinefelter - tall stature, hypogonadism, gynaecomastia
- Prader-Willi - hypotonia, hyperphagia, obesity, hypogonadism, short stature
- Noonan - short stature, pulmonary stenosis, webbed neck, normal karyotype (RASopathy)
- Coeliac disease, inflammatory bowel disease, cystic fibrosis, chronic kidney disease
- Cranial irradiation for childhood cancer -> GH deficiency first, then other axes
- Septo-optic dysplasia - optic nerve hypoplasia + absent septum pellucidum + hypopituitarism
Outcomes
- Constitutional delay: normal adult height, reached late
- Untreated GH deficiency: severe short stature, plus adult metabolic phenotype (central adiposity, dyslipidaemia, reduced BMD and quality of life)
- Turner syndrome untreated: adult height ~20 cm below target; GH plus oestrogen improves this
- Coeliac and IBD: catch-up growth occurs only if treated before epiphyseal fusion - the therapeutic window closes
- Once epiphyses fuse, no intervention adds height - which is why a delayed diagnosis of a treatable cause is the real harm
🔒
13 more sections, plus exam facts
Premium unlocks every note across every specialty, and the full exam fact library behind it.
Get premium access